These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
268 related items for PubMed ID: 24482101
1. Serum immunoglobulin free light chain and heavy/light chain measurements in POEMS syndrome. Wang C, Su W, Zhang W, Di Q, Duan MH, Ji W, Cao XX, Zhou DB, Li J. Ann Hematol; 2014 Jul; 93(7):1201-6. PubMed ID: 24482101 [Abstract] [Full Text] [Related]
2. Serum immunoglobulin free light chain measurements and heavy chain isotype usage provide insight into disease biology in patients with POEMS syndrome. Stankowski-Drengler T, Gertz MA, Katzmann JA, Lacy MQ, Kumar S, Leung N, Hayman SR, Buadi F, Kyle RA, Rajkumar SV, Dispenzieri A. Am J Hematol; 2010 Jun; 85(6):431-4. PubMed ID: 20513121 [Abstract] [Full Text] [Related]
3. POEMS Syndrome with IgG-λ/IgA-κ Biclonal Gammopathy and Abnormal Serum Free Light Chain Ratio: a Case Report. Ham JY, Suh JS, Lee WK, Song KE. Ann Clin Lab Sci; 2015 Jun; 45(6):702-6. PubMed ID: 26663802 [Abstract] [Full Text] [Related]
4. Free light chains and heavy/light chains in monitoring POEMS patients. Altinier S, Proko K, Zaninotto M, Ciubotaru D, Seguso M, Varagnolo M, Lessi F, Briani C, Adami F, Plebani M. Clin Chem Lab Med; 2016 Jun 01; 54(6):1065-71. PubMed ID: 27071150 [Abstract] [Full Text] [Related]
5. Prognostic value of serum heavy/light chain ratios in patients with POEMS syndrome. Wang C, Su W, Cai QQ, Cai H, Ji W, Di Q, Duan MH, Cao XX, Zhou DB, Li J. Eur J Haematol; 2016 Jul 01; 97(1):48-54. PubMed ID: 26383741 [Abstract] [Full Text] [Related]
6. The association of serum-free light-chain levels with markers of renal function. Erdem BK, Davran F, Yilmaz VT, Çetinkaya R, Akbas H. Ren Fail; 2015 Jul 01; 37(6):1057-60. PubMed ID: 26056734 [Abstract] [Full Text] [Related]
7. Tacrolimus has immunosuppressive effects on heavy/light chain pairs and free light chains in patients after heart transplantation: A relationship with infection. Lavríková P, Sečník P, Kubíček Z, Jabor A, Hošková L, Franeková J. Transpl Immunol; 2018 Oct 01; 50():43-47. PubMed ID: 29913223 [Abstract] [Full Text] [Related]
8. Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials. Lopez-Anglada L, Cueto-Felgueroso C, Rosiñol L, Oriol A, Teruel AI, Lopez de la Guia A, Bengoechea E, Palomera L, de Arriba F, Hernandez JM, Granell M, Peñalver FJ, Garcia-Sanz R, Besalduch J, Gonzalez Y, Martinez RB, Hernandez MT, Gutierrez NC, Puerta P, Valeri A, Paiva B, Blade J, Mateos MV, San Miguel J, Lahuerta JJ, Martinez-Lopez J, GEM (Grupo Español de MM)/PETHEMA (Programa para el Estudio de la Terapéutica en Hemopatías Malignas) Cooperative Study Group. PLoS One; 2018 Oct 01; 13(9):e0203392. PubMed ID: 30192814 [Abstract] [Full Text] [Related]
9. The prognostic utility and the association of serum light chains (free and total) and absolute lymphocyte count in patients with newly diagnosed diffuse large B-cell lymphoma. Han X, Wang J, Zhang N, Yao J, Feng Y, Li D, Liu P, Yang J, Zhou S, Qin Y, Yang S, Gui L, He X, Shi Y. Leuk Res; 2014 Nov 01; 38(11):1291-8. PubMed ID: 25287608 [Abstract] [Full Text] [Related]
10. [Detection of serum free light chain and its clinical significance in nonsecretory multiple myeloma]. Chen HF, Hou J, Yuan ZG, Wang DX, Fu WJ, Chen YB. Zhonghua Xue Ye Xue Za Zhi; 2008 Feb 01; 29(2):113-6. PubMed ID: 18681313 [Abstract] [Full Text] [Related]
11. Serum free light chains in clinical laboratory diagnostics. Jenner E. Clin Chim Acta; 2014 Jan 01; 427():15-20. PubMed ID: 23999048 [Abstract] [Full Text] [Related]
13. A case report: isolated a heavy chain monoclonal gammopathy in a patient with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin change syndrome. Kim SK, Park IK, Park BH, Park W, Lee HS, Kim TH, Jun JB, Bae SC, Yoo DH, Uhm WS. Int J Clin Pract Suppl; 2005 Apr 01; (147):26-30. PubMed ID: 15875614 [Abstract] [Full Text] [Related]
14. Characterization of immunoglobulin λ light chain variable region (IGLV) gene and its relationship with clinical features in patients with POEMS syndrome. Li J, Huang Z, Duan MH, Zhang W, Chen M, Cao XX, Guan HZ, Tian Z, Zhou DB. Ann Hematol; 2012 Aug 01; 91(8):1251-5. PubMed ID: 22453306 [Abstract] [Full Text] [Related]
15. Are renal reference intervals required when screening for plasma cell disorders with serum free light chains and serum protein electrophoresis? Abadie JM, van Hoeven KH, Wells JM. Am J Clin Pathol; 2009 Feb 01; 131(2):166-71. PubMed ID: 19141376 [Abstract] [Full Text] [Related]
17. Heavy/light chain assay in the monitoring of multiple myeloma. Ting HY, Sthaneshwar P, Bee PC, Shanmugam H, Lim M. Pathology; 2019 Aug 01; 51(5):507-511. PubMed ID: 31253381 [Abstract] [Full Text] [Related]
18. The serum heavy/light chain immunoassay: A valuable tool for sensitive paraprotein assessment, risk, and disease monitoring in monoclonal gammopathies. Greil C, Ihorst G, Gaiser F, Salzer U, Bisse E, Kastritis E, Ludwig H, Wäsch R, Engelhardt M. Eur J Haematol; 2017 Nov 01; 99(5):449-458. PubMed ID: 28886228 [Abstract] [Full Text] [Related]
19. Immunoglobulin heavy light chain test quantifies clonal disease in patients with AL amyloidosis and normal serum free light chain ratio. Prokaeva T, Spencer B, Sun F, O'Hara RM, Seldin DC, Connors LH, Sanchorawala V. Amyloid; 2016 Dec 01; 23(4):214-220. PubMed ID: 27677679 [Abstract] [Full Text] [Related]